GPC3 and hepatocellular carcinoma: Furthermore, serum GPC-3 concentrations > 150 pg/mL were independently associated with reduced OS in patients with HCC; its prognostic value appeared even more pronounced in patients with advanced tumors who were candidates for disease-control therapies.